Masimo to Present at Stifel 2017 Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Stifel 2017 Healthcare
Conference at the Palace Hotel in New York on Tuesday, November 14, 2017 at 9:30 a.m. Eastern Time. A live audiocast of the
presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient
outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. In 1995, the company debuted
Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple
studies to significantly reduce false alarms and accurately monitor for true alarms. Masimo SET® is estimated to be used
on more than 100 million patients in leading hospitals and other healthcare settings around the world. In 2005, Masimo introduced
rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that
previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and more recently, Pleth Variability Index
(PVI®) and Oxygen Reserve Index (ORI™), in addition to SpO2, pulse rate and perfusion index (PI). In 2014,
Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open
Connect™ (MOC-9™) interface. Masimo is also taking an active leadership role in mHealth with products such as
the Radius-7™ wearable patient monitor and the MightySat™ fingertip pulse oximeter. Additional information
about Masimo and its products may be found at www.masimo.com .
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive
Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI and ORI are trademarks or registered trademarks of
Masimo Corporation
Masimo
Investor Contact:
Eli Kammerman, (949) 297-7077
ekammerman@masimo.com
or
Media Contact:
Irene Paigah, (858) 859-7001
irenep@masimo.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20171107005717/en/